Skip to main content
. Author manuscript; available in PMC: 2010 Aug 10.
Published in final edited form as: J Rheumatol. 2008 Feb 1;35(3):429–437.

Table 3.

Miami MCTD cohort compared to the Missouri MCTD cohort. Data are number (%).

Characteristic All Miami MCTD,
n = 21
Miami Hispanic MCTD,
n = 12
Missouri MCTD,
n = 51
Raynaud's††** 18 (86) 11 (92) 45 (90)
Hand swelling††** 16 (76) 10 (83) 41 (85)
Alopecia* 16 (76) 8 (73) 14 (29)
Synovitis††** 16 (76) 12 (100) 40 (81)
Dry eyes and/or dry mouth††** 12 (57) 8 (73) 22 (59)
Lymphopenia††** 12 (57) 9 (75) 30 (67)
Gastroesophageal reflux** 11 (52) 6 (50) 40 (80)
Pericarditis or pleuritis††** 10 (48) 2 (18) 19 (37)
Photosensitivity††** 8 (38) 6 (55) 22 (45)
Myositis††** 8 (38) 5 (50) 14 (28)
Sclerodactyly** 4 (19) 4 (33) 25 (50)
Malar rash** 3 (14) 2 (18) 20 (42)
Renal disease††** 2 (9) 1 (9) 6 (12)

p < 0.05 comparing Miami MCTD cohort and Missouri MCTD cohort (Fisher's exact test).

††

No significant differences between the Miami MCTD cohort and the Missouri MCTD (Fisher's exact test).

*

p < 0.05 comparing Hispanic MCTD cohort and Missouri MCTD cohort (Fisher's exact test).

**

No significant differences between the Miami Hispanic MCTD cohort and the Missouri MCTD cohort (Fisher's exact test).